MiNK Therapeutics, Inc. (INKT)

NASDAQ

$10.62

$+0.14

(+1.37%)

After-Hours

MiNK Therapeutics, Inc. (INKT) Live Price Chart

Last updated: ⁦2026-10-27 21:15:20⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

MiNK Therapeutics, Inc. (INKT) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $10.62, with a market capitalization of $54.65M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $8.48 to $16.93. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$54.65M
Open	$10.48
Day's High	$221.55
Day's Low	$4.56
Previous Close	$10.43
Volume	9.80K
Average Volume	14.27K
P/E Ratio	--
52-Week High	$16.93
52-Week Low	$8.48
Dividend Yield	--
Earnings Date	--

MiNK Therapeutics, Inc. (INKT) After-Hours Stock Price

MiNK Therapeutics, Inc. (INKT) is trading at $10.60 in after-hours trading as of 2026-10-27 21:08:00, up 1.63% ($0.17) from the regular-session close of $10.43.

After-hours trading shows how investors are pricing INKT after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.

MiNK Therapeutics, Inc. (INKT) 7-Day Stock Price Change

Over the past seven days, MiNK Therapeutics, Inc. (INKT) moved from $9.41 to $10.62, representing a gain of 12.90% ($1.21).

The stock traded between $9.19 and $11.68 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.

The average daily volume was 15.36 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

INKT 52-Week Price Position

Position in Range: 25.4%

52W Low$8.48

52W High$16.93

INKT is currently trading at $10.62, placing it 25.4% of the way from its 52-week low of $8.48 to its 52-week high of $16.93. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is MiNK Therapeutics, Inc. (INKT)?

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.

MiNK Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	15
Exchange	NASDAQ
Company Website	https://www.minktherapeutics.com

How to Buy MiNK Therapeutics, Inc. (INKT) Stock on MEXC

Eligible investors can buy real shares of MiNK Therapeutics, Inc. (INKT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for INKT and Place Your Order

Open the RealStocks trading page and search for INKT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is MiNK Therapeutics, Inc. (INKT) stock price today?

MiNK Therapeutics, Inc. (INKT) is currently trading at $ 10.62, up 1.86% ($0.19) from the previous close of $ 10.43. Intraday prices update in real time during regular trading hours.

2.Is INKT stock going up or down today?

As of 2026-10-27 21:08:00, INKT is trading at $ 10.62, up 1.86% ($0.19) from its previous close of $ 10.43. The stock has traded between $ 4.56 and $ 221.55 during today’s regular session. Past price movements do not guarantee future results.

3.What is INKT pre-market price?

As of 2026-10-27 21:08:00, INKT is trading at $ 10.49 in pre-market trading, up 0.58% ($0.06) from the previous close of $ 10.43. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is INKT after-hours price?

As of 2026-10-27 21:08:00, INKT is trading at $ 10.60 in after-hours trading, up 1.63% ($0.17) from the regular-session close of $ 10.43. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is INKT stock trading now?

INKT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does INKT sit relative to its 52-week high and low?

Over the past 52 weeks, INKT has traded between a low of $ 8.48 and a high of $ 16.93. At $ 10.62, the stock is positioned 25.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is MiNK Therapeutics, Inc. in?

MiNK Therapeutics, Inc. (INKT) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is MiNK Therapeutics, Inc.'s market capitalization and where is it listed?

MiNK Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 54.65M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is INKT valued in terms of P/E ratio and EPS?

INKT trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.23. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does MiNK Therapeutics, Inc. pay a dividend?

MiNK Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.